×
Back to Agenda
Session 1: Keynote Address: Innovative Therapies, Processes and the Growing Role for Pharmacovigilance
Session Chair(s)
William Gregory, PHD
Senior Director, Safety and Risk Management, Pfizer Inc, United States
Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP
Strategy , Consultant, United Kingdom
Session Chair
Speaker(s)
James Wabby, MHS
VP, Head of Regulatory Strategy, Emerging Technologies and Combination Products, AbbVie, United States
Hans-Georg Eichler, MD, MSC
Consulting Physician, Austrian Association of Social Security Bodies, Austria
Have an account?